Second poster ESGCT 2023

It’s been reported that up to 30% of patients are diagnosed for rare disorders that have an approved CGT therapy, only a half of diagnosed patients receive CGT treatment. Can we get more effective?

We're excited to present our second poster at the 30th Annual Congress of the European Society for Cell and Gene Therapy (ESGCT) in Brussels from October 24-27, 2023. ????

Poster will be share at poster session: "How can we get more effective in implementing cell gene therapy in practice ?"

Our aim goes beyond just sharing findings; we're here to ignite a lively discussion on this crucial topic. Together, let's explore strategies, innovations, and solutions to enhance the real-world application of cell gene therapy.

Join us soon at ESGCT 2023

Contact me and let's arrange a meeting. See you there!


See all articles >


Medasol s. r. o.
Drtinova 10
150 00 Praha 5

Registration address:
U poštovky 1269/2
150 00 Praha 5

+420 724 333 313